D.E. Shaw & Co’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-64,300
Closed -$9.01M 4304
2020
Q3
$9.01M Buy
64,300
+24,300
+61% +$2.96M 0.01% 1305
2020
Q2
$3.01M Buy
+40,000
New +$2.09M ﹤0.01% 2080

D.E. Shaw & Co's LVGO Position: Q3 2020 in Review

D.E. Shaw & Co sold out of Livongo Health, Inc. Common Stock (LVGO) in Q3 2020, closing a stake of 52,083 shares — an estimated $6.35M sold.

D.E. Shaw & Co first reported a position in LVGO in Q2 2020 and held it in 1 quarter. The position peaked at $3.92M in Q2 2020. 391 funds tracked by Wall St. Rank hold LVGO as of Q3 2020.

  • D.E. Shaw & Co reported no remaining Livongo Health, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • D.E. Shaw & Co sold 52,083 Livongo Health, Inc. Common Stock shares in Q3 2020, an estimated $6.35M.
  • D.E. Shaw & Co first reported a position in Livongo Health, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • D.E. Shaw & Co's Livongo Health, Inc. Common Stock position peaked at $3.92M in Q2 2020.
  • 391 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q3 2020.

Based on D.E. Shaw & Co's 13F filing for Q3 2020, filed 16 Nov 2020.